Literature DB >> 22201765

Molecular insights into primary hyperoxaluria type 1 pathogenesis.

Barbara Cellini1, Elisa Oppici, Alessandro Paiardini, Riccardo Montioli.   

Abstract

Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder of glyoxylate metabolism caused by the deficiency of liver peroxisomal alanine:glyoxylate aminotransferase (AGT), a pyridoxal 5'-phosphate (PLP)-dependent enzyme. The PH1 pathogenesis is mostly due to single point mutations (more than 150 so far identified) on the AGXT gene, and is characterized by a marked heterogeneity in terms of genotype, enzymatic and clinical phenotypes. This article presents an up to date review of selected aspects of the biochemical properties of the two allelic forms of AGT and of some PH1-causing variants. These recent discoveries highlight the effects at the protein level of the pathogenic mutations, and, together with previous cell biology and clinical data, (i) improve the understanding of the molecular basis of PH1 pathogenesis, and (ii) help to delineate perspectives for predicting the response to pyridoxine treatment or for suggesting new strategies for PH1 patients bearing the analyzed mutations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201765     DOI: 10.2741/3948

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  11 in total

1.  Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6.

Authors:  Mirco Dindo; Elisa Oppici; Daniele Dell'Orco; Rosa Montone; Barbara Cellini
Journal:  J Inherit Metab Dis       Date:  2017-11-06       Impact factor: 4.982

2.  Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy.

Authors:  Thomas A VanderJagt; Monica H Neugebauer; Marilee Morgan; Donald W Bowden; Vallabh O Shah
Journal:  World J Diabetes       Date:  2015-08-10

Review 3.  New insights into the pathogenesis of renal calculi.

Authors:  Herman Singh Bagga; Thomas Chi; Joe Miller; Marshall L Stoller
Journal:  Urol Clin North Am       Date:  2012-10-23       Impact factor: 2.241

4.  Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?

Authors:  Agnieszka Pozdzik; Cristina David; Jelle Vekeman; Frederik Tielens; Michel Daudon
Journal:  IJU Case Rep       Date:  2021-05-13

5.  Effect of alanine supplementation on oxalate synthesis.

Authors:  Kyle D Wood; Brian L Freeman; Mary E Killian; Win Shun Lai; Dean Assimos; John Knight; Sonia Fargue
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-28       Impact factor: 5.187

6.  Interaction of human Dopa decarboxylase with L-Dopa: spectroscopic and kinetic studies as a function of pH.

Authors:  Riccardo Montioli; Barbara Cellini; Mirco Dindo; Elisa Oppici; Carla Borri Voltattorni
Journal:  Biomed Res Int       Date:  2013-05-26       Impact factor: 3.411

7.  Biochemical and computational approaches to improve the clinical treatment of dopa decarboxylase-related diseases: an overview.

Authors:  Barbara Cellini; Riccardo Montioli; Elisa Oppici; Carla Borri Voltattorni
Journal:  Open Biochem J       Date:  2012-12-11

8.  Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.

Authors:  Elisa Oppici; Krisztian Fodor; Alessandro Paiardini; Chris Williams; Carla Borri Voltattorni; Matthias Wilmanns; Barbara Cellini
Journal:  Proteins       Date:  2013-06-01

9.  S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation.

Authors:  Riccardo Montioli; Alessandro Roncador; Elisa Oppici; Giorgia Mandrile; Daniela Francesca Giachino; Barbara Cellini; Carla Borri Voltattorni
Journal:  Hum Mol Genet       Date:  2014-07-02       Impact factor: 6.150

10.  Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) AGXT Gene Mutation.

Authors:  Prince Singh; Fouad T Chebib; Andrea G Cogal; Dimitar K Gavrilov; Peter C Harris; John C Lieske
Journal:  Kidney Int Rep       Date:  2020-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.